Immediate Impact
1 from Science/Nature 62 standout
Citing Papers
TGF-β signaling in health, disease and therapeutics
2024 Standout
Drug repurposing for cancer therapy
2024 Standout
Works of Caela Miller being referenced
Is FDA-Approved Bevacizumab Cost-Effective When Included in the Treatment of Platinum-Resistant Recurrent Ovarian Cancer?
2016
MEK1/2 inhibitors in the treatment of gynecologic malignancies
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Caela Miller | 73 | 122 | 71 | 86 | 19 | 294 | |
| Gülten Oskay-Özcelik | 35 | 105 | 60 | 78 | 31 | 336 | |
| Neil T. Phippen | 69 | 63 | 43 | 66 | 30 | 271 | |
| C. Roemer-Bécuwe | 88 | 73 | 37 | 103 | 15 | 335 | |
| Pratibha Binder | 129 | 106 | 54 | 39 | 26 | 272 | |
| Stephen Fiascone | 49 | 78 | 40 | 115 | 16 | 312 | |
| Hiromasa Sasaki | 65 | 51 | 127 | 73 | 33 | 312 | |
| Andrea Jewell | 34 | 63 | 29 | 96 | 26 | 272 | |
| A. Gentry-Maharaj | 52 | 67 | 16 | 66 | 14 | 301 | |
| Serena Maria Boccia | 43 | 86 | 24 | 41 | 22 | 217 | |
| Wen‐Shiung Liou | 122 | 93 | 62 | 52 | 25 | 289 |
All Works
Loading papers...